Comparative insight into surfactants mediated amyloidogenesis of lysozyme

被引:68
作者
Chaturvedi, Sumit K. [1 ]
Khan, Javed M. [1 ,2 ]
Siddiqi, Mohammad K. [1 ]
Alam, Parvez [1 ]
Khan, Rizwan H. [1 ]
机构
[1] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India
[2] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci, POB 2460, Riyadh 11451, Saudi Arabia
关键词
Surfactants; pH; Lysozyme; Amyloid fibril and aggregation; EGG-WHITE LYSOZYME; SODIUM DODECYL-SULFATE; BOVINE SERUM-ALBUMIN; AMYLOID FIBRILS; IN-VITRO; PROTEIN AGGREGATION; SECONDARY STRUCTURE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; VARIANTS;
D O I
10.1016/j.ijbiomac.2015.11.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Electrostatic and hydrophobic interactions have an important role in the protein aggregation. In this study, we have investigated the effect of charge and hydrophobicity of oppositely charged surfactants i.e., anionic (AOT and SDS) and cationic (CTAB and DTAB) on hen egg white lysozyme at pH 9.0 and 13.0, respectively. We have employed various methods such as turbidity measurements, Rayleigh light scattering, ThT, Congo red and ANS dye binding assays, far-UV CD, atomic force microscopy, transmission electron and fluorescence microscopy. At lower molar ratio, both anionic and cationic surfactants promote amyloid fibril formation in lysozyme at pH 9.0 and 13.0, respectively. The aggregation was proportionally increased with respect to protein concentration and hydrophobicity of surfactant. The morphology of aggregates at both the pH was fibrillar in structure, as visualized by dye binding and microscopic imaging techniques. Initially, the interaction between surfactants and lysozyme was electrostatic and then hydrophobic as investigated by ITC. This study demonstrates the crucial role of charge and hydrophobicity during amyloid fibril formation. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:315 / 325
页数:11
相关论文
共 66 条
[1]   Ca2+, within the physiological concentrations, selectively accelerates Aβ42 fibril formation and not Aβ40 in vitro [J].
Ahmad, Atta ;
Muzaffar, Mahvish ;
Ingram, Vernon M. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (10) :1537-1548
[2]  
Alam P., 2014, CELL BIOCH BIOPHYS, P1
[3]   Interactions of gemini surfactants with two model proteins: NMR, CD, and fluorescence spectroscopies [J].
Amiri, Razieh ;
Bordbar, Abdol-Khalegh ;
Garcia-Mayoral, MaFlor ;
Khosropour, Ahmad Reza ;
Mohammadpoor-Baltork, Iraj ;
Menendez, Margarita ;
Laurents, Douglas V. .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2012, 369 :245-255
[4]   Thermally induced fibrillar aggregation of hen egg white lysozyme [J].
Arnaudov, LN ;
de Vries, R .
BIOPHYSICAL JOURNAL, 2005, 88 (01) :515-526
[5]   Test for cooperativity in the early kinetic intermediate in lysozyme folding [J].
Bachmann, A ;
Segel, D ;
Kiefhaber, T .
BIOPHYSICAL CHEMISTRY, 2002, 96 (2-3) :141-151
[6]   Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis [J].
Berson, JF ;
Theos, AC ;
Harper, DC ;
Tenza, D ;
Raposo, G ;
Marks, MS .
JOURNAL OF CELL BIOLOGY, 2003, 161 (03) :521-533
[7]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[8]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[9]   Sulfated Glycosaminoglycans Accelerate Transthyretin Amyloidogenesis by Quaternary Structural Conversion [J].
Bourgault, Steve ;
Solomon, James P. ;
Reixach, Natalia ;
Kelly, Jeffery W. .
BIOCHEMISTRY, 2011, 50 (06) :1001-1015
[10]   CHEMICAL-STABILITY OF INSULIN .2. FORMATION OF HIGHER MOLECULAR-WEIGHT TRANSFORMATION PRODUCTS DURING STORAGE OF PHARMACEUTICAL PREPARATIONS [J].
BRANGE, J ;
HAVELUND, S ;
HOUGAARD, P .
PHARMACEUTICAL RESEARCH, 1992, 9 (06) :727-734